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Supplementary figure 1. In the original high-throughput screening conditions 
substituted chloroisocoumarins dramatically enhance invasion of host-cells. 
Representative images for attachment/invasion assays using GFP-parasites (green 
particles) following a single 50 µM treatment of JCP174 (enhancer) or DMSO (vehicle) 
using the red/green assay described in the methods section (Yellow particles indicate 
GFP parasites labeled with an antibody conjugated to an alexafluor594 fluorophore). 
Scale bar, 100 µm. 
 
 
 
  
Supplementary figure 2. Enhancer compounds are dependent upon the aromatic 
amine in the 7-substituent position for activity. a, Structure of the inactive JCP174 
analogue (JCP174-IA). b, Representative images for attachment/invasion assays using 
RFP-parasites following a single 50 µM treatment of JCP174, JCP174-IA or DMSO 
(vehicle) using the red/green assay described in the methods section. Blue = DAPI 
stained host-cell nuclei; Red = RFP expressing tachyzoites; Yellow = RFP expressing 
tachyzoites labeled with an antibody conjugated to an alexa488 fluorophore. Scale bar, 
100 µm. 
      
Supplementary figure 3. JCP174-alkyne behaves the same as the unmodified parent 
compound. a, Structure of JCP174-alkyne (JCP174-alk). b, Representative images for 
attachment/invasion assays using RFP-parasites with a single 50 µM treatment of 
JCP174-alk or DMSO (vehicle) using the red/green assay described in the methods 
section. Blue = DAPI stained host-cell nuclei; Red = RFP expressing tachyzoites; Yellow 
= RFP expressing tachyzoites labeled with an antibody conjugated to an alexa488 
fluorophore. Scale bar, 100 µm. c, Activity-based probe (ABP) competition assays of FP-
rhodamine labeled serine hydrolase targets in tachyzoites lysates comparing JCP174-alk 
to DMSO (control) and JCP174 (parent compound). Arrowhead indicates principal target 
of competition. 
 
  
Supplementary figure 4. TgPPT1WT and TgPPT1S128A can be expressed and purified 
from E. coli. a, Coomassie stained SDS-PAGE gel of uninduced (UN) and induced (IN)  
samples from an E. coli expression culture for TgPPT1WT and TgPPT1S128A. Arrowhead 
indicates induced protein species. b, Coomassie stained gel of samples taken following a 
representative purification of TgPPT1WT, as described in the methods section. 
 
 Supplementary figure 5. TgPPT1-HAdd is cytosolically localized and rapidly 
degraded upon removal of Shield-1. a, Cellular localization of TgPPT1-HAdd by 
indirect immunofluorescent assay, and conditional knockdown of TgPPT1-HAdd upon 
removal of Shield-1. HA, anti-HA Ab. tubulin, anti-tubulin Ab. Scale bar, 6 µm. b, 
Timecourse of knock-down of TgPPT1-HAdd upon removal of Shield-1 observed 
through FP-rhodamine labeling of residual TgPPT1-HAdd activity (rho, top panel with 
the labeled species indicated by a single arrowhead) and Western blot of total TgPPT1-
HAdd protein levels (HA, middle panel). SAG1, loading control. Double arrowhead 
indicates HA-positive doublet sometimes observed in the HAdd-tagged strain following 
FP-rhodamine labeling. 
 Supplementary figure 6. PCR verification of TgPPT1 knockout. a, Schematic of the 
knockout plasmid (pTKO-TgPPT1), the native TgPPT1 locus, and the expected genomic 
rearrangement resulting from double cross-over homologous recombination of pTKO-
TgPPT1 with the TgPPT1 locus to generate ∆TgPPT1. Expected points of recombination 
are indicated with dashed lines. T1 and T2; 5´ and 3´ targeting regions. HXGPRT; 
hypoxanthine-xanthine-guanine phosphoribosyl transferase drug selection cassette. 
Arrows indicate positions and names of primers used to verify the predicted rearrangment 
of the TgPPT1 locus. b, Three ∆TgPPT1 clones (B2, SG1, SG2) were compared 
alongside untransfected wild-type (WT) in three different PCR reactions: 5´: integration 
specific PCR using primers 5´-for and 5´-rev to give an expected PCR product of 1.2 kb. 
3´: integration specific PCR using primers 3´-for and 3´-rev to give an expected PCR 
product of 1.9 kb. locus: PCR to amplify native TgPPT1 locus using primers L-for and L-
rev to give an expected PCR product of 0.4 kb. Clone SG1 was selected and used for all 
subsequent studies described. 
 
 
 
Supplementary figure 7. ∆TgPPT1 parasites are indistinguishable from wild-type in 
their ability to attach to and invade host cells. Invasion assays were performed using 
equal numbers of parasites (input = 1 x 106 parasites/well). The standard red/green assay 
was used as described in the methods section. a, Total number of parasites (attached plus 
invaded) relative to wild type for wild-type (WT) and ∆TgPPT1. There is no significant 
difference between the two strains in terms of the total number of parasites counted (raw 
mean counts: wild-type total = 2405, SEM +/- 154.4; ∆TgPPT1 total = 2260.9, SEM +/- 
261.9). b, Fractions of the respective totals counted as attached or invaded plotted as 
percent of the total number counted for that parasite line. The fraction of the total number 
of parasites that have attached and invaded is not significantly different for the two 
parasite lines (raw mean counts: wild-type attached = 599.1, SEM +/- 0.8; wild-type 
invaded = 1805.9, SEM +/- 153.6; ∆TgPPT1 attached = 707.4, SEM +/- 64.8; ∆TgPPT1 
invaded = 1553.5, SEM +/- 197.1). Student’s t-test; “n.s” indicates no significant 
difference with the P value shown; means +/- SEM for n = 8 experiments. 
 
 
 
 
Supplementary figure 8. Palmostatin-B competes for FP-rhodamine labeling of the 
TgPPT1 species in gel, and enhances invasion of host-cells. a, Activity-based probe 
(ABP) competition assays of FP-rhodamine labeled serine hydrolase targets in tachyzoite 
lysates using vehicle (DMSO),  50 µM JCP174 and a titration of palmostatin-B (palmo-
B). Arrowhead indicates principal target of competition for JCP174 and palmostatin-B. b, 
Attachment/invasion assays with a titration of palmostatin-B using the red/green assay 
described in the methods section. Student’s t-test; asterisk indicates significance with the 
P value shown; means +/- SEM for n = 8 experiments. 
 
 
Supplementary figure 9. Toxoplasma tachyzoites can be metabolically labeled with 
17-octadecynoic acid (17-ODA). SDS-PAGE of azido-rhodamine “Clicked” sample 
(rho) of the membrane fractions prepared from tachyzoites (RH1) metabolically labeled 
with DMSO or 17-ODA. 
 
 
 
 Supplementary figure 10. Normalized residual azido-rhodamine labeling of TgPPT1 
substrates following digestion with TgPPT1WT and TgPPT1S128A. Western blot signal 
intensities were normalized to buffer treated control to generate a protein loading 
normalization factor. The fluorescent signal for the rhodamine labeling of the 
palmitoylated substrates was measured and adjusted for background signal intensity, and 
then normalized according protein loading values. The final normalized fluorescence 
intensity values (representing residual rhodamine labeling of substrates following 
digestion) were expressed as a percentage of the buffer treated control (100%), and 
plotted as such for the enzymatic treatments with either TgPPT1WT or TgPPT1S128A. 
Student’s t-test; asterisk indicates significance with the P value shown; means +/- SD for 
n = 3 independent experiments. 
 
  
 
  
 
 
 Supplementary figure 11. Full Western blots and fluorescent gel scans. Red boxes 
indicate regions cropped for main figures. a, blots for figure 1e. b, coomassie stained gel 
and fluorescent gel scans for figure 2d and 2e. c, blots and fluorescent gel scans for figure 
5a-f. Arrowheads indicate non-specific labeling by antibodies or azido-rhodamine 
following Click reactions.  
 
 
 
 
 
Supplementary table 1. Combined data for parallel mass-spectrometry target 
identification approaches. See Excel spreadsheet for data. See Methods section for a 
description of the triaging approach taken for these preliminary datasets. 
 
Supplementary table 2. Stringent analysis of the MS data identifies TGGT1_083860, 
a putative phospholipase/carboxylesterase as the principal target of JCP174. See 
Excel spreadsheet for data. 
 
Supplementary table 3. µM IC50s for compound inhibition of TgPPT1. 
 
 
Supplementary table 4. DNA Primers. 
Primer name Nucleotide sequence (5´- 3´) 
TgPPT1-amplify-FOR CAATAAGTACATATGGCGTCTCTCCAGCCAGG 
TgPPT1-amplify-REV GTTAAATTTGGATCCTCATCAGTTTGTTGTGAGGACGTTTTCG 
TgPPT1-S128A-FOR CGAATTATCCTCGCAGGATTCGCTCAAGGCGGCGCCCTCGCCTAC 
TgPPT1-S128A-REV GTAGGCGAGGGCGCCGCCTTGAGCGAATCCTGCGAGGATAATTCG 
TgPPT1-DD target primer P1 TACTTCCAATCCAATTTAGCTCCAGTCGACACTCCAGC 
TgPPT1-DD target primer P2 TCCTCCACTTCCAATTTTAGCGTTTGTTGTGAGGACGTTTTCGATG 
TgPPT1-KO 5' target FOR CGTTTTGCCGGATTCTCGAGATTCCTTTCTTCCCTAAGAGTCC 
TgPPT1-KO 5' target REV GAGAAGCACAGGAATTCGAGCTGGAGTGTCGACTGG 
TgPPT1-KO 3' target FOR CGACGAACAAGCTTAGACAGTCTGCGAAGCTGGAGG 
TgPPT1-KO 3' target REV GTCACGAGGGCCCCACCGCTACAAGTGAACGTGTACACC 
TgPPT1 5' integration screen FOR GAAGTGCTGAAGACTGTATACTGG 
TgPPT1 5' integration screen REV CAATTAACCCTCACTAAAGGGAACAAAAGC 
TgPPT1 3' integration screen FOR CAAGGACGCAGAAAGGAACAAACACCG 
TgPPT1 3' integration screen REV GAACACATGGACAGCGAATGAAGG 
TgPPT1-locus check FOR CCTCGCCTCCAAGCAGCGCATCG 
TgPPT1-locus check REV GCCTCTGCGTAGTGTCGTCTCACG 
 
 
